Clinical Research Directory
Browse clinical research sites, groups, and studies.
StrataCTX® as a Steroid Sparing Device
Sponsor: Columbia University
Summary
The purpose is to determine if StrataCTX® can be used as a steroid sparing agent for the treatment of cutaneous reactions related to, cutaneous T Cell lymphoma (CTCL) and chemotherapy/immunotherapy treatments than the current standard treatment - topical steroids - in people who are receiving treatment for CTCL, or chemotherapy/immunotherapy for solid/hematologic malignancies. Subjects will have CTCL and are being treated with topical steroids, or being treated with chemotherapy/immunotherapy for another condition and have had cutaneous reactions that have warranted initiation of topical steroids.
Official title: Post-marketing Surveillance of StrataCTX® Flexible Wound Dressing for Use as a Steroid Sparing Agent
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2021-07-07
Completion Date
2026-08
Last Updated
2025-10-02
Healthy Volunteers
No
Conditions
Interventions
StrataCTX® gel
Gel forming flexible wound dressing for the prevention and treatment of radiation dermatitis
Locations (1)
Columbia University Irving Medical Center
New York, New York, United States